Rice ML, et al. - Authors assessed the development of cataracts or ocular hypertension in patients with Duchenne muscular dystrophy (DMD) on long-term glucocorticoid (GC) treatment. At the mean age of 12.9 ± 4.1 years, cataract formation was first documented. With a higher risk among deflazacort patients, in patients undergoing GC therapy for DMD, the rate of cataract formation was slow and well tolerated. Very small percentage of patients requiring cataract extraction or with ocular hypertension was observed. As per data, experts noted that a schedule of annual eye examinations was appropriate.